177
Participants
Start Date
September 29, 2015
Primary Completion Date
June 19, 2017
Study Completion Date
December 4, 2017
Reslizumab
Reslizumab 110 mg was administered by qualified study personnel as subcutaneous injections in the upper arm(s) once every 4 weeks for a total of 6 doses. Drug was supplied in pre-filled syringes.
Placebo
Placebo was administered by qualified study personnel as subcutaneous injections in the upper arm(s) once every 4 weeks for a total of 6 doses. Drug was supplied in pre-filled syringes.
Non-Oral Corticosteroid (non-OCS) Asthma Medication
Participants continue using their non-OCS background asthma medications without change during the study's treatment period.
Oral Corticosteroid (OCS)
After screening and prior to study start, the participant's OCS dose was adjusted to determine the minimal effective OCS requirement.
Teva Investigational Site 37059, Brussels
Teva Investigational Site 20087, Rosario
Teva Investigational Site 58251, Kyiv
Teva Investigational Site 78091, New Lambton
Teva Investigational Site 51233, Hatvan
Teva Investigational Site 58237, Kyiv
Teva Investigational Site 78092, Box Hill
Teva Investigational Site 78097, Frankston
Teva Investigational Site 32574, Leipzig
Teva Investigational Site 37058, Gembloux
Teva Investigational Site 78089, Bedford Park
Teva Investigational Site 78093, Kent Town
Teva Investigational Site 20055, Mendoza
Teva Investigational Site 78090, Nedlands
Teva Investigational Site 51232, Dombóvár
Teva Investigational Site 51254, Csorna
Teva Investigational Site 51253, Szombathely
Teva Investigational Site 32576, Berlin
Teva Investigational Site 32573, Berlin
Teva Investigational Site 32578, Berlin
Teva Investigational Site 30154, Genova
Teva Investigational Site 31161, Girona
Teva Investigational Site 32580, Rostock
Teva Investigational Site 58246, Vinnytsia
Teva Investigational Site 13358, Fairfax
Teva Investigational Site 13366, Charleston
Teva Investigational Site 32579, Hanover
Teva Investigational Site 21106, Chihuahua City
Teva Investigational Site 13344, Miami
Teva Investigational Site 13354, Pembroke Pines
Teva Investigational Site 13351, Homestead
Teva Investigational Site 13372, Miami
Teva Investigational Site 13346, Tampa
Teva Investigational Site 13368, Sebring
Teva Investigational Site 21104, Durango
Teva Investigational Site 13342, Kissimmee
Teva Investigational Site 13343, Saint Cloud
Teva Investigational Site 13362, Biloxi
Teva Investigational Site 58249, Kremenchuk
Teva Investigational Site 58243, Sumy
Teva Investigational Site 21094, Guadalajara
Teva Investigational Site 21091, Guadalajara
Teva Investigational Site 21100, Guadalajara
Teva Investigational Site 21093, Guadalajara
Teva Investigational Site 80091, Kfar Saba
Teva Investigational Site 13349, Cincinnati
Teva Investigational Site 31160, Valencia
Teva Investigational Site 31158, Valencia
Teva Investigational Site 13345, Michigan City
Teva Investigational Site 58245, Dnipro
Teva Investigational Site 58238, Dnipropetrovsk
Teva Investigational Site 80084, Petah Tikva
Teva Investigational Site 35185, Lille
Teva Investigational Site 32622, Frankfurt
Teva Investigational Site 13367, Chicago
Teva Investigational Site 58244, Kharkiv
Teva Investigational Site 58235, Kharkiv
Teva Investigational Site 58239, Kharkiv
Teva Investigational Site 58241, Kharkiv
Teva Investigational Site 13363, Normal
Teva Investigational Site 13350, St Louis
Teva Investigational Site 13352, St Louis
Teva Investigational Site 21103, Monterrey
Teva Investigational Site 21101, Monterrey
Teva Investigational Site 13348, Lenexa
Teva Investigational Site 35187, Strasbourg
Teva Investigational Site 58242, Zhaporizhzhya
Teva Investigational Site 35189, Lyon
Teva Investigational Site 13371, Clermont
Teva Investigational Site 13370, Edmond
Teva Investigational Site 13347, Oklahoma City
Teva Investigational Site 13377, Dallas
Teva Investigational Site 58240, Ivano-Frankivsk
Teva Investigational Site 80082, Rehovot
Teva Investigational Site 21105, Querétaro
Teva Investigational Site 13369, Houston
Teva Investigational Site 32621, Bad Wörishofen
Teva Investigational Site 30152, Catanzaro
Teva Investigational Site 13365, Long Beach
Teva Investigational Site 80083, Jerusalem
Teva Investigational Site 13357, Bakersfield
Teva Investigational Site 50384, Moscow
Teva Investigational Site 50357, Saint Petersburg
Teva Investigational Site 50417, Chelyabinsk
Teva Investigational Site 50419, Yekaterinburg
Teva Investigational Site 50383, Novosibirsk
Teva Investigational Site 50386, Novosibirsk
Teva Investigational Site 50418, Tomsk
Teva Investigational Site 50358, Tomsk
Teva Investigational Site 50385, Kemerovo
Teva Investigational Site 50382, Kemerovo
Teva Investigational Site 50356, Barnaul
Teva Investigational Site 80085, Haifa
Teva Investigational Site 13356, New York
Teva Investigational Site 20059, Buenos Aires
Teva Investigational Site 20058, Buenos Aires
Teva Investigational Site 20056, Buenos Aires
Teva Investigational Site 20057, Buenos Aires
Teva Investigational Site 20066, San Rafael
Teva Investigational Site 20052, Córdoba
Teva Investigational Site 20050, Mendoza
Teva Investigational Site 20051, San Miguel de Tucumán
Teva Investigational Site 54133, Břeclav
Teva Investigational Site 54132, Jindřichův Hradec
Teva Investigational Site 35186, Le Kremlin-Bicêtre
Teva Investigational Site 21102, Distrito Federal
Teva Investigational Site 21090, Mexico City
Teva Investigational Site 38084, Leeuwarden
Teva Investigational Site 38085, Zwolle
Teva Investigational Site 53316, Gdansk
Teva Investigational Site 53318, Krakow
Teva Investigational Site 53319, Lodz
Teva Investigational Site 53321, Lodz
Teva Investigational Site 53322, Lubin
Teva Investigational Site 53320, Ostrów Wielkopolski
Teva Investigational Site 53358, Rzeszów
Teva Investigational Site 53317, Tarnów
Teva Investigational Site 53323, Wroclaw
Teva Investigational Site 87020, Goyang-si
Teva Investigational Site 87024, Jeonju
Teva Investigational Site 87025, Seongnam-si
Teva Investigational Site 87023, Seoul
Teva Investigational Site 87022, Seoul
Teva Investigational Site 87021, Seoul
Teva Investigational Site 31159, Barcelona
Teva Investigational Site 58248, Kyiv
Teva Investigational Site 58250, Kyiv
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY